IMMIX BIOPHARMA INC.
1,6000
05-ноября-24 14:59:59
15 мин. задержка
Акции
+0,0200
+1,27%
Сегодняшний диапазон
1,4800 - 1,6000
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
07 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Doses Additional Patients in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
13 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
20 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
19 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
13 дек 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
ImmixBio Releases and Ships Scaled-Up GMP Batches of IMX-110 for Clinical Trial Patient Dosing
12 дек 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
25 окт 2022 07:00:32 Источник Nasdaq GlobeNewswire
-
18 окт 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
ImmixBio Completes GMP Manufacturing of Scaled-Up Batch of IMX-110 for Clinical Trials
07 сен 2022 11:05:34 Источник Nasdaq GlobeNewswire
-
Immix Biopharma Announces Share Repurchase Program
09 май 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
05 апр 2022 08:30:00 Источник Nasdaq GlobeNewswire
-
Immix Biopharma, Inc. Announces IMMX Milestone Day to be Held on April 5, 2022
07 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
ImmixBio Initiates GMP Manufacturing of IMX-120, a Biologic for Inflammatory Bowel Disease
22 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
ImmixBio Management Answers Top-Voted Investor Questions at IMMX Investors Day February 1, 2022
01 фев 2022 08:30:00 Источник Nasdaq GlobeNewswire
-
ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data
31 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire